TWiV 1134: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses Merck's RSV preventative monoclonal antibody Clesrovimab before reviewing the recent statistics on SARS-CoV-2 infection, if previous SARS-COV-2 infections predict the outcome of subsequent infections, if using COVID rapid diagnostic tests is cost effective, if the protein based vaccine NVX-CoV2327 elicits a durable immune response, if combination treatment of vaccine and antiviral drugs effectively protect against hospitalization, where to find PEMGARDA, what do when healthcare workers succumb to SARS-CoV-2 infection, and how COVID-19 may alter the cognitive trajectories of older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Clesrovimab, RSV preventative monoclonal antibody for infants (Merck)
- COVID-19 national trend (CDC)
- COVID-19 deaths (CDC)
- Characterizing SARS-CoV-2 reinfections and long COVID (Communications Medicine)
- Cost-effectiveness of COVID rapid diagnostic tests (PLoS Medicine)
- NVX-CoV2373 against pre-Delta and Delta strains of COVID-19 little evidence of waning immune response (CID)
- Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization(CID)
- Pemgarda infusion center locator (Pemgarda)
- Respiratory virus guidance (CDC)
- Early phase of SARS-CoV-2 infection (COVID.gov)
- NIH COVID-19 treatment guidelines (NIH)
- Infectious Disease Society guidelines for treatment and management (ID Society)
- Drug interaction checker (University of Liverpool)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (ID Society)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,dexamethasone at the right time (OFID)
- Anticoagulation guidelines (hematology.org)
- Cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection(Nature Aging)
- Contribute to our Floating Doctors fundraiser
- Letters read on TWiV 1134
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
More description
In his weekly clinical update, Dr. Griffin discusses Merck's RSV preventative monoclonal antibody Clesrovimab before reviewing the recent statistics on SARS-CoV-2 infection, if previous SARS-COV-2 infections predict the outcome of subsequent infections, if using COVID rapid diagnostic tests is cost effective, if the protein based vaccine NVX-CoV2327 elicits a durable immune response, if combination treatment of vaccine and antiviral drugs effectively protect against hospitalization, where to find PEMGARDA, what do when healthcare workers succumb to SARS-CoV-2 infection, and how COVID-19 may alter the cognitive trajectories of older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Clesrovimab, RSV preventative monoclonal antibody for infants (Merck)
- COVID-19 national trend (CDC)
- COVID-19 deaths (CDC)
- Characterizing SARS-CoV-2 reinfections and long COVID (Communications Medicine)
- Cost-effectiveness of COVID rapid diagnostic tests (PLoS Medicine)
- NVX-CoV2373 against pre-Delta and Delta strains of COVID-19 little evidence of waning immune response (CID)
- Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization(CID)
- Pemgarda infusion center locator (Pemgarda)
- Respiratory virus guidance (CDC)
- Early phase of SARS-CoV-2 infection (COVID.gov)
- NIH COVID-19 treatment guidelines (NIH)
- Infectious Disease Society guidelines for treatment and management (ID Society)
- Drug interaction checker (University of Liverpool)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (ID Society)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,dexamethasone at the right time (OFID)
- Anticoagulation guidelines (hematology.org)
- Cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection(Nature Aging)
- Contribute to our Floating Doctors fundraiser
- Letters read on TWiV 1134
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.